Professor Belch graduated as a Doctor from the University of Glasgow (MB ChB), becoming a Lecturer within the University Department of Medicine, where she completed her Research MD degree (1st class Honours, winner of Belahouston Gold Medal) in 1987. She was appointed Senior Lecturer with Honorary Consultant status at the University Department of Medicine in Ninewells Hospital, Dundee, also in 1987, and became Professor of Vascular Medicine in 1995. She was Director of the Tayside Clinical Trials Centre before becoming the Director of the Tayside Medical Science Centre (TASC) and the Tayside R&D Director until December 2015. She was also Co-Director of the Medical Research Institute in the University of Dundee, then Research Dean and Co-Dean of the Medical School again until 2015. She is a founder Fellow of the Academy of Medical Science, and a Fellow and Council Member of the Royal Society, Edinburgh. She is President of her specialty’s Learned Society, The Section of Vascular Medicine, Royal Society of Medicine. She is on the Board of the European Society of Medicine. She is a medical tribunal member of the Medical Professions Tribunal Service, appointed 2016. She is an accredited, trained to level 4, inter-personal mediator.

Professor Belch research interests include: Vascular Medicine especially Peripheral Arterial Disease Vascular Risk especially inflammatory aspects Connective tissue disease with a focus on Systemic Sclerosis

Rothwell PM, Wilson M, Price JF, Belch JJF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379 (9826): 159-601. DOI:10.1016/S0140-6736 (12) 60209-8. Rothwell PM, Price JF, Fowkes GR, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JJF, Wilson M, Mehta Z, Meade TW. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379 (9826): 1602-1612. DOI:10.1016/S0140-6736 (11) 61720-0. Creager MA, Olin JW, Belch JJF, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR. Effect of Hypoxia-Inducible Factor-1α Gene Therapy on walking performance in patients with intermittent claudication. Circulation 2011; 124: 1765-1773. Belch JJF, Hiatt WR, Baumgartner MD I, Driver IV, Nikol S, Norgren L, Van Belle E, on behalf of the TAMARIS Committees and Investigators. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. The Lancet, 2011, Vol. 377 No. 9781 pp 1929-1937 Rothwell PM, Fowkes FGR, Belch JJF, Ogawa H, Chew E, Warlow CP, Peto R, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet 2011 (Jan 1); 377 (No. 9759): 3-4 Belch JJF, Dormandy J, Biasi GM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepantalo M, Norgen L, Hiatt WR, Becquemin JP, Berqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A. Clopidogrel and Acetylsalicylic acid in bypass Surgery for Peripheral ARterial disease: Results of the randomized, placebo-controlled CASPAR Trial. Journal of Vascular Surgery 2010 Oct;52(4):825-33, 833.e1-2. Epub 2010 Aug 1. Greenhalgh RM, Belch JJF, Brown LC, Gaines PA, Gao L, Reise JA, Thompson SG: Mimic Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease. European Journal of Vascular & Endovascular Surgery 2008; 36 (6): 680-688. Galarraga B, Belch JJF, Pullar T, Ogston S, Khan F. Clinical improvement in Rheumatoid Arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. Journal of Rheumatology 2010; 37(3): 521-528. Belch JJF, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R, Lee R, Bancroft J, MacEwan S, Shepherd J, Macfarlane P, Morris A, Jung R, Kelly C, Connacher A, Peden N, Jamieson A, Matthews D, Leese G, McKnight J, O'Brien I, Semple C, Petrie J, Gordon D, Pringle S, MacWalter R: Prevention of Progression of Arterial Disease and Diabetes Study Group, Diabetes Registry Group, Royal College of Physicians Edinburgh. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. British Medical Journal 2008; 337: 1030-1033. Galarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C, Ogston S, Nuki G, Belch JJF. Cod liver oil (N-3 fatty acids) as a non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology 2008; 47 (5): 665-669. Galarraga B, Khan F, Kumar P, Pullar T, Belch JJF. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology 2008; 47 (12): 1780-4. George J, Carr E, Davies J, Belch JJF, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 2006; 114 (23): 2508-2516. Khan F, Belch JJF MacLeod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom pre-eclampsia develops. Hypertension 2005; 46: 1123-1128. Belch JJF, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin III JR, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA. Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. (Editorial) Archives of Internal Medicine 2003; 163 (8): 884-92. Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJF. Rheumatoid arthritis and macrovascular disease. Rheumatology 2003; 42 (2): 292-297. Ho M, Veale JD, Eastmond C, Nuki G, Belch JJF. Macrovascular disease and systemic sclerosis. Annals of Rheumatic Diseases 2000; 59 (1): 39-43. Belch JJF, Shaw JW, Kirk G, McLaren M, Robb R, Maple C, Morse P. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 1997; 95 (8): 2027-2031. Belch JJF, Bell PRF, Coleridge-Smith P, Creissen D, Dormandy JA, Kester RC, McCollum RD, Mizushima Y, Ruckley CV, Scurr JH, Wolfe JHN. A randomized double-blind placebo controlled study evaluating the efficacy and safety of AS-013, a PGE1 prodrug in patients with intermittent claudication. Circulation 1997; 95 (9): 2298-2302. Khan F, Greig IR, Newton DJ, Butler A, Belch JJF. Skin blood flow after transdermal S-nitrosothio-acetylglucose. The Lancet 1997; 350 (9075): 410-411. Taylor JE, Henderson IS, Stewart WK, Belch, JJF. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients. The Lancet 1991; 338 (8779): 1361-1362. McMurray J, McLay J, Chopra M, Bridges A, Belch, JJF. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. American Journal of Cardiology 1990; 65 (18): 1261-1262. McKenzie J, Belch, JJF, Land D, Park R, McKillop J. Oesophageal ischaemia in motility disorders associated with chest pain. The Lancet 1988; 2 (8611): 592-595. Belch, JJF, Madhok R, Shaw, B, Leiberman P, Forbes CD, Sturrock RD. Double-blind trial of CL115,347, a transdermally absorbed prostaglandin E2 analogue, as a treatment for Raynaud's phenomenon. Lancet 1985; 1 (8439): 1180-1183. Belch, JJF, McKay A, McArdle B, Lowe GDO, Pollock JG, Leiberman P, Forbes CD, Prentice CRM. A double blind study of the effect of prostacyclin infusion in severe peripheral vascular disease. Lancet 1983; 1 (8320): 315-317. Belch, JJF, Newman P, Drury JK, McKenzie F, Leiberman P, Capell HA, Forbes CD, Prentice CRM. Intermittent prostacyclin infusions in patients with Raynaud's syndrome: a double blind trial. Lancet 1983; 1 (8320): 313-315.